TY - BOOK AU - National Academies of Sciences, Engineering, and Medicine A2 - Joe Alper A2 - Eeshan Khandekar A2 - Carolyn Shore TI - Virtual Clinical Trials: Challenges and Opportunities: Proceedings of a Workshop SN - 978-0-309-49488-5 DO - 10.17226/25502 PY - 2019 UR - https://nap.nationalacademies.org/catalog/25502/virtual-clinical-trials-challenges-and-opportunities-proceedings-of-a-workshop PB - The National Academies Press CY - Washington, DC LA - English KW - Health and Medicine AB - Successful drug development relies on accurate and efficient clinical trials to deliver the best and most effective pharmaceuticals and clinical care to patients. However, the current model for clinical trials is outdated, inefficient and costly. Clinical trials are limited by small sample sizes that do not reflect variations among patients in the real world, financial burdens on participants, and slow processes, and these factors contribute to the disconnect between clinical research and clinical practice. On November 28-29, the National Academies of Sciences, Engineering, and Medicine convened a workshop to investigate the current clinical trials system and explore the potential benefits and challenges of implementing virtual clinical trials as an enhanced alternative for the future. This publication summarizes the presentations and discussions from the workshop. ER -